rLP2086

1 clinical trials · Condition

Record	Firm	Date
A Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years. (NCT01323270)	Pfizer	2011-03-18

Every clearance here is in the API, with alerts when new ones post.